#Inhalational Anaesthetic Agents

> <p style="color:purple";> Describe the effects of inhalational agents on the cardiovascular, respiratory and central nervous systems</p>

<!--></!-->

> <p style="color:purple";> Describe the toxicity of inhalational agents </p>

<!--></!-->

> <p style="color:purple";> Describe the comparative pharmacology of ~~nitrous oxide~~, halothane, enflurane, isoflurane, desflurane, sevoflurane, xenon and ether</p>

##Common Features of Inhalation Agents

|Property|Action|
|--|--|
|**Resp**|All halogenated agents ↓ V<sub>T</sub> and ↑ RR, with an overall ↓ in MV and therefore cause PaCO<sub>2</sub> to ↑; and ↓ sensitivity of central respiratory centres to CO<sub>2</sub>.
|**CVS**|
|**CNS**|
|**Immune**|
|**Metabolic**|
|**Toxic Effects**|

##Specific Features of Inhalation Agents
|Property|Action|
|--|--|
|**Resp**|All halogenated agents ↓ V<sub>T</sub> and ↑ RR, with an overall ↓ in MV and therefore cause PaCO<sub>2</sub> to ↑; and ↓ sensitivity of central respiratory centres to CO<sub>2</sub>.
|**CVS**|
|**CNS**|
|**Immune**|
|**Metabolic**|
|**Toxic Effects**|



↓ HR, ↑



